Company page
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. is a public company listed under the ticker IKT, operating in the American market. The company has a market capitalization of approximately $223.1 million. Inhibikase focuses on developing innovative therapies for neurodegenerative diseases.
- Ticker
- IKT
- Market cap
- $223.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major